VistaGen Therapeutics, Inc.
VTGN
$1.97
-$0.08-3.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.22% | -8.70% | -20.76% | -12.73% | -49.94% |
| Total Depreciation and Amortization | 3.11% | 2.55% | 3.97% | 2.72% | 2.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.62% | 0.62% | -14.81% | 116.10% | 4.14% |
| Change in Net Operating Assets | -3.67% | 182.24% | 166.25% | -176.73% | 95.28% |
| Cash from Operations | 2.12% | 5.57% | -0.16% | -55.60% | -47.15% |
| Capital Expenditure | -- | 100.00% | -45.24% | -44.83% | 9.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 245.73% | 94.54% | -42.40% | -- | -- |
| Cash from Investing | 224.88% | 94.58% | -42.42% | -18,751.72% | 9.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -100.00% |
| Issuance of Common Stock | 66.61% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 66.61% | -- | -100.00% | 123.16% | -100.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.43% | 48.96% | -14.92% | -119.75% | -108.31% |